Ability Biologics Announces the Closing of its US $18M Seed Funding Extension Toward the Generation of Novel, Highly Targeted Immunomodulators June 18, 2024
Ability Biologics Announces the Closing of its US $18M Seed Funding Extension Toward the Generation of Novel, Highly Targeted Immunomodulators June 18, 2024